Session 1. Nucleic Acids as Therapeutic Agents

Chair & Speaker: Tamara Martínez – Sylentis / Speakers: Mano Manoharan (Alnylam-USA), Miguel Moreno (Aptus Biotech – Spain) and Beatriz Llamusí (Arthex Biotech – Spain)
Chairs: Jorge Beleta (SDDN)/ Emilio Diez (e10Bio) / Speakers: Thomas Eichholtz, CSO (Chiesi Pharmaceutici – Italy), Damià Tormo (Columbus Venture Partners – Spain) and Jordi Gracia (Evotec – France)
Chair: Marie Helène Larraufie (Almirall -Spain) / Speakers: Bernat Crosas (Institute of Molecular Biology Barcelona, Spain), David Zollman (University of Dundee, Scotland -UK), Carlos Galdeano (University of Barcelona-Spain), Marta Isasa (Odissey Therapeutics – UK)
Chair & Speaker: Domingo Gargallo, ABAC Therapeutics / Speakers: Rafael Cantón, (Hospital Ramon y Cajal, Madrid, Spain), Concepción González-Bello, (University Santiago de Compostela-Spain) and Sergio Lociuro ( Bioversys AG – Basel, Switzerland)
Chair and Speaker : Francesc Mitjans ( LEITAT- Spain) / Speakers: Luis Álvarez-Vallina (Cancer Immunotherapy Unit ,12 de Octubre University Hospital- Spain), and Claus Møller ( Denmark)